David F Williams Selected Research

Warfarin (Coumadin)

3/2007

Anticoagulation with warfarin in vitreoretinal surgery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David F Williams Research Topics

Disease

5	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 10/2012
4	Macular Edema 01/2022 - 05/2006
2	Retinal Vein Occlusion 01/2022 - 12/2021
2	Retinal Detachment (Retinal Detachments) 08/2019 - 11/2011
2	Retinal Perforations 08/2019 - 11/2011
2	Osteoarthritis 12/2014 - 07/2013
2	Neoplasms (Cancer) 05/2014 - 04/2013
1	Heart Valve Diseases (Valvular Heart Disease) 01/2022
1	Rheumatic Heart Disease (Rheumatic Heart Diseases) 01/2021
1	Myopia 08/2019
1	Hypotension (Low Blood Pressure) 01/2019
1	Endophthalmitis (Ophthalmia) 01/2018
1	Inflammation (Inflammations) 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Geographic Atrophy 01/2017
1	Heart Failure 01/2015
1	Thrombosis (Thrombus) 01/2015
1	Pelvic Organ Prolapse 05/2014
1	Rheumatic Diseases (Rheumatism) 07/2013
1	Breast Neoplasms (Breast Cancer) 04/2013
1	Cardiotoxicity 04/2013
1	Body Weight (Weight, Body) 04/2013
1	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2013
1	Stroke (Strokes) 10/2012
1	Choroidal Neovascularization 10/2012
1	Osteoporosis 09/2012
1	Disease Progression 03/2007
1	Hemorrhage 03/2007
1	Edema (Dropsy) 05/2006
1	Infections 07/2004

Drug/Important Bio-Agent (IBA)

6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2018
2	Biocompatible Materials (Biomaterials)IBA 01/2017 - 05/2014
2	Retinaldehyde (Retinal)IBA 03/2013 - 11/2011
1	PolymersIBA 01/2022
1	Endothelial Growth FactorsIBA 12/2021
1	InflammasomesIBA 01/2017
1	lampalizumabIBA 01/2017
1	salicylhydroxamic acid (SHAM)IBA 01/2017
1	chemotactic factor inactivatorIBA 01/2017
1	Complement Factor D (Factor D)IBA 01/2017
1	Complement Factor I (C3b Inactivator)IBA 01/2017
1	Siloxanes (Siloxane)IBA 01/2015
1	Polyurethanes (Polyurethane)IBA 01/2015
1	polycarbonateIBA 01/2015
1	Hyaluronic Acid (Hyaluronan)IBA 12/2014
1	Polypropylenes (Polypropylene)IBA 05/2014
1	CytokinesIBA 07/2013
1	MicellesIBA 04/2013
1	Inosine Diphosphate (IDP)IBA 03/2013
1	Ranibizumab (Lucentis)FDA Link 10/2012
1	Therapeutic UsesIBA 09/2012
1	Warfarin (Coumadin)FDA LinkGeneric 03/2007
1	Pioglitazone (Actos)FDA Link 05/2006
1	Rosiglitazone (Avandia)FDA Link 05/2006
1	ThiazolidinedionesIBA 05/2006
1	Biological Control AgentsIBA 07/2004

Therapy/Procedure

9	Therapeutics 01/2022 - 09/2012
2	Vitrectomy 08/2019 - 11/2011
2	Intravitreal Injections 01/2018 - 01/2017
2	Scleral Buckling 11/2011 - 03/2007
1	Injections 12/2021
1	Stents 01/2019
1	Aftercare (After-Treatment) 01/2018
1	Heart-Assist Devices 01/2015
1	Transplantation 01/2015
1	Lasers (Laser) 05/2006